These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7537180)
1. Immunohistochemical localization of transforming growth factor-alpha, epidermal growth factor receptor and c-erbB-2 protein in hyperplastic human prostates. Giri DK; Pal R; Wadhwa SN; Talwar GP Carcinogenesis; 1995 Apr; 16(4):729-33. PubMed ID: 7537180 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates. De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409 [TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Myers RB; Kudlow JE; Grizzle WE Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115 [TBL] [Abstract][Full Text] [Related]
4. The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions. Leav I; McNeal JE; Ziar J; Alroy J Hum Pathol; 1998 Jul; 29(7):668-75. PubMed ID: 9670822 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor, epidermal growth factor receptor, and transforming growth factor-alpha in human hyperplastic prostate tissue: expression and cellular localization. De Bellis A; Ghiandi P; Comerci A; Fiorelli G; Grappone C; Milani S; Salerno R; Marra F; Serio M J Clin Endocrinol Metab; 1996 Nov; 81(11):4148-54. PubMed ID: 8923874 [TBL] [Abstract][Full Text] [Related]
6. Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study. Tørring N; Møller-Ernst Jensen K; Lund L; Nielsen JE; Djurhuus JC; Poulsen SS; Nexø E BJU Int; 2002 Apr; 89(6):583-90. PubMed ID: 11942969 [TBL] [Abstract][Full Text] [Related]
7. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Ching KZ; Ramsey E; Pettigrew N; D'Cunha R; Jason M; Dodd JG Mol Cell Biochem; 1993 Sep; 126(2):151-8. PubMed ID: 7508078 [TBL] [Abstract][Full Text] [Related]
8. Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates. Gann PH; Klein KG; Chatterton RT; Ellman AE; Grayhack JT; Nadler RB; Lee C Prostate; 1999 Sep; 40(4):248-55. PubMed ID: 10420153 [TBL] [Abstract][Full Text] [Related]
9. Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods. Maddy SQ; Chisholm GD; Hawkins RA; Habib FK J Endocrinol; 1987 Apr; 113(1):147-53. PubMed ID: 2438365 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels. Yang Y; Chisholm GD; Habib FK Br J Cancer; 1993 Jan; 67(1):152-5. PubMed ID: 7678977 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. Sherwood ER; Lee C World J Urol; 1995; 13(5):290-6. PubMed ID: 8581000 [TBL] [Abstract][Full Text] [Related]
12. Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study. Giri DK; Wadhwa SN; Upadhaya SN; Talwar GP Prostate; 1993; 23(4):329-36. PubMed ID: 7505056 [TBL] [Abstract][Full Text] [Related]
13. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701 [TBL] [Abstract][Full Text] [Related]
14. Expression of androgen receptor and growth factors in premalignant lesions of the prostate. Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433 [TBL] [Abstract][Full Text] [Related]
15. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients. Umekita Y; Ohi Y; Sagara Y; Yoshida H Int J Cancer; 2000 Nov; 89(6):484-7. PubMed ID: 11102891 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression. Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121 [TBL] [Abstract][Full Text] [Related]
17. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH). Sciarra F Ann N Y Acad Sci; 1995 Jun; 761():66-78. PubMed ID: 7542859 [TBL] [Abstract][Full Text] [Related]
18. Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic gliomas. von Bossanyi P; Sallaba J; Dietzmann K; Warich-Kirches M; Kirches E Pathol Res Pract; 1998; 194(3):141-7. PubMed ID: 9587931 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate. Kumar VL; Majumder PK; Gujral S; Kumar V Cancer Lett; 1998 Dec; 134(2):177-80. PubMed ID: 10025878 [TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues. Cohen DW; Simak R; Fair WR; Melamed J; Scher HI; Cordon-Cardo C J Urol; 1994 Dec; 152(6 Pt 1):2120-4. PubMed ID: 7525998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]